{"title":"New HCV treatment paradigms--now also for patients with HIV.","authors":"H. Albrecht","doi":"10.1056/AC201104040000007","DOIUrl":null,"url":null,"abstract":"This year, we will witness a major paradigm shift in the treatment of hepatitis C virus (HCV) infection. The protease inhibitors boceprevir and","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"60 3 1","pages":"40"},"PeriodicalIF":0.0000,"publicationDate":"2011-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal watch. AIDS clinical care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/AC201104040000007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This year, we will witness a major paradigm shift in the treatment of hepatitis C virus (HCV) infection. The protease inhibitors boceprevir and
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
